Esomeprazole
Sold as Nexiam, *Omiflynt, Nexmezol, Nexomep, Nexipraz otc, Esoran, Nesopram, Nexipraz, Trustan, Axiago iv, Aspepraz, Nexilok, Nexipraz iv, Nectizole otc, Esomeprazole jubilant, Esomeprazole unicorn, Truloc, Jubigord, Esomeprazole cipla, Nexgastro, Urdala, Mitogut, Emzol, Merpax iv, Hetenex, Esprawin, Nexiflux, Nectizole, Repigut, Dispep, Nexes otc, Esomex, Peptimep, Merpax, Gisisum, Esocid otc, Esocid, Esomeprazole iv cipla, Nectizole iv, Gactazel, Hetaflux, Essium iv, Esomeprazole cospharma, Emanera, Atalyd, Truloc otc, Nextell otc, Esomeprazole austell, Trusfluks, Nexiam iv
6-Methoxy-2-[(S)-(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole
Drag to rotate. Structure from PubChem CID 9568614.
Background
Registration
- Applicants
- 26
- Registrations
- 80
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Astrazeneca Pharmaceuticals (Pty) Ltd | Nexiam, Axiago iv, Nexiam iv | 2,5 mg, 5 mg, 10 mg, 20 mg, 40 mg | 350263, 350264, 421003, 440208, 440209, 450779, A380384 | Not determined | None |
| Sandoz South Africa (Pty) Ltd | *Omiflynt, Nexmezol, Nexomep | 20, 40 | 440335, 440336, 440337, 440338 | Not determined | None |
| Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd, Pharmaco Distribution (Pty) Ltd | Nexipraz otc, Nexipraz, Nexipraz iv | 20, 30 mg, 40 mg | 450121, 450125, 450126, 460606 | S4S2 to S4 by pack | PIPIL |
| Ranbaxy (SA) (Pty) LtdCancelled | Esoran, Nesopram | 20, 40 | 450122, 450123, 450124 | Not determined | None |
| Acino Pharma (Pty) Ltd | Trustan, Nexes otc | 20 mg, 40 mg | 450777, 450778, 481116 | Not determined | PIPIL |
| Pharmacare limited û woodmeadCertificate held by Pharmacare limited | Aspepraz | 40 mg | 460079 | S4 | PIPIL |
| Teva Pharmaceuticals (Pty) LtdCertificate held by Teva Pharmaceuticals (Pty) Ltd,1 of 2 cancelled | Nexilok | 0,6 mg, 20mg | 460506, 460507 | S2 | PI |
| Jubilant Pharma SA (Pty) Ltd | Nectizole otc, Esomeprazole jubilant, Jubigord | 20, 40 | 470163, 470164, 470449, 470450 | Not determined | None |
| Unicorn Pharmaceuticals (Pty) Ltd | Esomeprazole unicorn | 20, 40 | 470200, 470201 | Not determined | None |
| Pharma Dynamics (Pty) Ltd | Truloc, Truloc otc | 20 mg, 40 mg | 470320, 470321, 570833 | S4 | PIPIL |
| Cipla Medpro (Pty) Ltd | Esomeprazole cipla, Nexgastro, Urdala, Esomeprazole iv cipla, Atalyd | 2,5, 5, 10, 20 MG, 40 | 470744, 470746, 470747, 510442, 560155, 560158.155, 590069, 590070, 590071.069, 590072.070 | Not determined | None |
| Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr Reddyõs Laboratories (Pty) Ltd | Mitogut | 40 mg | 470800 | Not determined | PIPIL |
| Emcure- Pharmaceutical South Africa (Pty) Ltd | Emzol | Not stated | 471148 | Not determined | None |
| Austell Pharmaceuticals (Pty) Ltd1 of 3 cancelled | Merpax iv, Nextell otc, Esomeprazole austell | 20 mg, 40 mg | 480023, 590222, 590223 | S2 | PIPIL |
| Hetero Drugs South Africa (Pty) Ltd2 of 5 cancelled | Hetenex, Gactazel, Hetaflux | 20 mg, 40 mg | 480088, 480089, 54/11.4.3/0281, 540283, 540285.281 | S4 | PIPIL |
| Zentiva South Africa (Pty) Ltd | Esprawin | 20, 40 | 480379, 480380 | Not determined | None |
| Astral Pharma (Pty) Ltd | Nexiflux | 20, 40 | 480436, 480437 | Not determined | None |
| Activo Health (Pty) Ltd | Nectizole, Nectizole iv | 20, 40 | 480438, 480439, 510932 | Not determined | None |
| Pharma-q Holdings (Pty) Ltd | Repigut | 20 mg, 40 mg | 480550, 480551 | Not determined | None |
| Innovata pharmaceuticals | Dispep, Trusfluks | 20, 40 | 480934, 480935, 590325, 590326 | Not determined | None |
| Accord Healthcare (Pty) Ltd | Esomex | 20, 40 | 490375, 490376 | Not determined | None |
| Unimed Healthcare (Pty) LtdCertificate held by Ruby Pharmaceuticals (Pty) Ltd | Peptimep, Essium iv | 20, 40 mg | 500031, 500032, 550476 | S4 | PIPIL |
| Ascendis Pharma (Pty) Ltd | Merpax, Gisisum | 20, 40 | 500286, 500287, 500288.286, 500289.287 | Not determined | None |
| Zydus Healthcare (Pty) Ltd | Esocid otc, Esocid | 40 | 500898, 500899 | Not determined | None |
| Cospharm Investments (Pty) Ltd | Esomeprazole cospharma | 40 mg | 550703 | Not determined | None |
| LHC Pharmaceuticals (Pty) Ltd | Emanera | 20 mg, 40 mg | 550910, 550911 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Nexiam 20 MG EACH TABLET CONTAINS ESOMEPRAZOLE 20,0 mg | 20 mg | 35026335/11.4.3/0263 | Registered | Not determined | None |
| Nexiam 40 MG EACH TABLET CONTAINS ESOMEPRAZOLE 40,0 mg | 40 mg | 35026435/11.4.3/0264 | Registered | Not determined | None |
| Nexiam 10 MG sachets EACH SACHET CONTAINS ESOMEPRAZOLE 10,0 mg | 10 mgSachets | 42100342/11.4.3/1003 | Registered | Not determined | None |
| Nexiam 2,5 MG sachets EACH SACHET CONTAINS ESOMEPRAZOLE 2,5 mg | 2,5 mgSachets | 44020844/11.4.3/0208 | Registered | Not determined | None |
| Nexiam 5 MG sachets EACH SACHET CONTAINS ESOMEPRAZOLE 5,0 mg | 5 mgSachets | 44020944/11.4.3/0209 | Registered | Not determined | None |
| *Omiflynt EACH TABLET CONTAINS ESOMEPRAZOLE 20,0 mg | Not listed | 44033544/11.4.3/0335 | Registered | Not determined | None |
| Nexmezol 40 EACH TABLET CONTAINS ESOMEPRAZOLE 40,0 mg | 40 | 44033644/11.4.3/0336 | Registered | Not determined | None |
| Nexomep 20 EACH TABLET CONTAINS ESOMEPRAZOLE 20,0 mg | 20 | 44033744/11.4.3/0337 | Registered | Not determined | None |
| Nexomep 40 EACH TABLET CONTAINS ESOMEPRAZOLE 4,0 mg | 40 | 44033844/11.4.3/0338 | Registered | Not determined | None |
| Nexipraz otc EACH TABLET CONTAINS ESOMEPRAZOLE 20,0 mg | 30 mgGastric-resistant tablets | 45012145/11.4.3/0121Approved 12 February 2024 | Registered | S2 | PIPIL |
| Esoran 40 EACH TABLET CONTAINS ESOMEPRAZOLE 40,0 mg | 40 | 45012245/11.4.3/0122 | Cancelled | Not determined | None |
| Nesopram 20 EACH TABLET CONTAINS ESOMEPRAZOLE 20,0 mg | 20 | 45012345/11.4.3/0123 | Cancelled | Not determined | None |
| Nesopram 40 EACH TABLET CONTAINS ESOMEPRAZOLE 40,0 mg | 40 | 45012445/11.4.3/0124 | Cancelled | Not determined | None |
| Nexipraz 20 EACH TABLET CONTAINS: ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE20,0 mg | 20Film-coated tablets | 45012545/11.4.3/0125Approved 14 September 2022 | Registered | S4 | PIPIL |
| Nexipraz 40 EACH TABLET CONTAINS: ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE40,0 mg | 40Film-coated tablets | 45012645/11.4.3/0126Approved 14 September 2022 | Registered | S4 | PIPIL |
| Trustan 20 MG EACH TABLET CONTAINS ESOMEPRAZOLE 20,0 mg | 20 mg | 45077745/11.4.3/0777 | Registered | Not determined | None |
| Trustan 40 MG EACH TABLET CONTAINS ESOMEPRAZOLE 40,0 mg | 40 mg | 45077845/11.4.3/0778 | Registered | Not determined | None |
| Axiago 40 MG iv EACH VIAL CONTAINS ESOMEPRAZOLE 40,0 mg | 40 mg | 45077945/11.4.3/0779 | Registered | Not determined | None |
| Aspepraz 40 MG injection EACH VIAL CONTAINS ESOMEPRAZOLE 40,0 mg | 40 mgInjection | 46007946/11.4.3/0079Approved 15 December 2024 | Registered | S4 | PIPIL |
| Nexilok 20 | 20mgGastro-resistant tablets | 46050646/11.4.3/0506Approved 27 August 2025 | Registered | S2 | PI |
| Nexilok 40 Each Tablet contains: Esomeprazole magnesium Dihydrate equivalent to Esomeprazole 40,0 mg | 0,6 mgTablet | 46050746/11.4.3/0507Approved 30 June 2026 | Cancelled | Not determined | None |
| Nexipraz iv EACH VIAL CONTAINS: ESOMEPRAZOLE SODIUM EQUIVALENT TO ESOMEPRAZOLE40,0 mg | 40 mgPowder for solution for injection & infusion | 46060646/11.4.3/0606Approved 2 March 2023 | Registered | S4 | PIPIL |
| Nectizole otc 20 Each tablet contains ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE 20,0 mg | 20 | 47016347/11.4.3/0163 | Registered | Not determined | None |
| Esomeprazole 40 jubilant Each tablet contains ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 | 47016447/11.4.3/0164 | Registered | Not determined | None |
| Esomeprazole 20 unicorn Each tablet contains ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE 20,0 mg | 20 | 47020047/11.4.3/0200 | Registered | Not determined | None |
| Esomeprazole 40 unicorn Each tablet contains ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 | 47020147/11.4.3/0201 | Registered | Not determined | None |
| Truloc 20 MG | 20 mgGastro-resistant film coated tablet | 47032047/11.4.3/0320Approved 17 November 2025 | Registered | S4 | PIPIL |
| Truloc 40 MG | 40 mgGastro-resistant film coated tablet | 47032147/11.4.3/0321Approved 17 November 2025 | Registered | S4 | PIPIL |
| Jubigord 20 Each tablet contains ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE 20,0 mg | 20 | 47044947/11.4.3/0449 | Registered | Not determined | None |
| Jubigord 40 Each tablet contains ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 | 47045047/11.4.3/0450 | Registered | Not determined | None |
| Esomeprazole 20 MG cipla Each tablet contains ESOMEPRAZOLE MAGNESIUM DIHYDRATE EQUIVALENT TO ESOMEPRAZOLE 20,0 mg | 20 MG | 47074447/11.4.3/0744 | Registered | Not determined | None |
| Nexgastro 20 Each tablet contains ESOMEPRAZOLE MAGNESIUM DIHYDRATE EQUIVALENT TO ESOMEPRAZOLE 20,0 mg | 20 | 47074647/11.4.3/0746 | Registered | Not determined | None |
| Urdala 40 Each tablet contains ESOMEPRAZOLE MAGNESIUM DIHYDRATE EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 | 47074747/11.4.3/0747 | Registered | Not determined | None |
| Mitogut 40 EACH VIAL CONTAINS ESOMEPRAZOLE 40,0 mg | 40 mg.Lyophilised powder for solution for injection and infusion. 40 mg/vial | 47080047/11.4.3/0800Approved 27 January 2021 | Registered | Not determined | PIPIL |
| Emzol Each vial contains ESOMEPRAZOLE SODIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | Not listed | 47114847/11.4.3/1148 | Registered | Not determined | None |
| Merpax iv Each vial contains ESOMEPRAZOLE SODIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | Not listed | 48002348/11.4.3/0023 | Registered | Not determined | None |
| Hetenex 20 MG EACH TABLET CONTAINS: ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE 20,0 mg | 20 mg | 48008848/11.4.3/0088 | Cancelled | Not determined | None |
| Hetenex 40 MG EACH TABLET CONTAINS: ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 mg | 48008948/11.4.3/0089 | Cancelled | Not determined | None |
| Esprawin 20 EACH TABLET CONTAINS ESOMEPRAZOLE 20,0 mg | 20 | 48037948/11.4.3/0379 | Registered | Not determined | None |
| Esprawin 40 EACH TABLET CONTAINS ESOMEPRAZOLE 40,0 mg | 40 | 48038048/11.4.3/0380 | Registered | Not determined | None |
| Nexiflux 20 EACH TABLET CONTAINS : ESOMEPRAZOLE 20,0 mg | 20 | 48043648/11.4.3/0436 | Registered | Not determined | None |
| Nexiflux 40 EACH TABLET CONTAINS : ESOMEPRAZOLE 40,0 mg | 40 | 48043748/11.4.3/0437 | Registered | Not determined | None |
| Nectizole 20 EACH TABLET CONTAINS :ESOMEPRAZOLE 20,0 mg | 20 | 48043848/11.4.3/0438 | Registered | Not determined | None |
| Nectizole 40 EACH TABLET CONTAINS :ESOMEPRAZOLE 40,0 mg | 40 | 48043948/11.4.3/0439 | Registered | Not determined | None |
| Repigut 20 MG Each Tablet Contains: Esomeprazole Magnesium Dihydrate equivalent to Esomeprazole 20,0 mg | 20 mg | 48055048/11.4.3/0550 | Registered | Not determined | None |
| Repigut 40 MG Each Tablet Contains: Esomeprazole Magnesium Dihydrate equivalent to Esomeprazole 40,0 mg | 40 mg | 48055148/11.4.3/0551 | Registered | Not determined | None |
| Dispep 20 Each gastro-resistant tablet contains ESOMEPRAZOLE MAGNESIUM DIHYDRATE EQUIVALENT TO ESOMEPRAZOLE 20,0 mg | 20 | 48093448/11.4.3/0934 | Registered | Not determined | None |
| Dispep 40 Each gastro-resistant tablet contains ESOMEPRAZOLE MAGNESIUM DIHYDRATE EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 | 48093548/11.4.3/0935 | Registered | Not determined | None |
| Nexes otc | 20 mgGastric-resistant tablets. | 48111648/11.4.3/1116Approved 1 February 2024 | Registered | Not determined | PIPIL |
| Esomex 20 Each tablet contains ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE 20,0 mg | 20 | 49037549/11.4.3/0375 | Registered | Not determined | None |
| Esomex 40 Each tablet contains ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 | 49037649/11.4.3/0376 | Registered | Not determined | None |
| Peptimep 20 EACH TABLET CONTAINS ESOMEPRAZOLE 20,0 mg | 20Gastro-resistant tablets | 50003150/11.4.3/0031Approved 17 February 2026 | Registered | S4 | PIPIL |
| Peptimep 40 EACH TABLET CONTAINS ESOMEPRAZOLE 40,0 mg | 40Gastro-resistant tablets | 50003250/11.4.3/0032Approved 17 February 2026 | Registered | S4 | PIPIL |
| Merpax 20 Each tablet contains ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE 20,0 mg | 20 | 50028650/11.4.3/0286 | Registered | Not determined | None |
| Merpax 40 Each tablet contains ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 | 50028750/11.4.3/0287 | Registered | Not determined | None |
| Gisisum 20 Each tablet contains ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE 20,0 mg | 20 | 500288.28650/11.4.3/0288.286 | Registered | Not determined | None |
| Gisisum 40 Each tablet contains ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 | 500289.28750/11.4.3/0289.287 | Registered | Not determined | None |
| Esocid otc Each tablet contains ESOMEPRAZOLE MAGNESIUM DIHYDRATE EQUIVALENT TO ESOMEPRAZOLE 20,0 mg | Not listed | 50089850/11.4.3/0898 | Registered | Not determined | None |
| Esocid 40 Each tablet contains ESOMEPRAZOLE MAGNESIUM DIHYDRATE EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 | 50089950/11.4.3/0899 | Registered | Not determined | None |
| Esomeprazole 40 iv cipla Each vial contains ESOMEPRAZOLE SODIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 | 51044251/11.4.3/0442 | Registered | Not determined | None |
| Nectizole iv Each vial contains ESOMEPRAZOLE SODIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | Not listed | 51093251/11.4.3/0932 | Registered | Not determined | None |
| Hetenex 40 injection EACH VIAL CONTAINS ESOMEPRAZOLE SODIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 mgPowder for solution for injection and infusion | 54/11.4.3/0281Approved 22 October 2024 | Registered | S4 | PIPIL |
| Gactazel 40 MG EACH VIAL CONTAINS ESOMEPRAZOLE SODIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 mgPowder for solution for injection and infusion | 54028354/11.4.3/283Approved 22 October 2024 | Registered | S4 | PI |
| Hetaflux 40 injection EACH VIAL CONTAINS ESOMEPRAZOLE SODIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 mgPowder for solution for injection and infusion | 540285.28154/11.4.3/0285.281Approved 22 October 2024 | Registered | S4 | PIPIL |
| Essium iv EACH VIALCONTAINS ESOMEPRAZOLE SODIUM EQUIVALENT TO ESOMEPROZOLE 40,0 mg | 40 mgPowder for injection | 55047655/11.4.3/0476Approved 18 July 2023 | Registered | S4 | PIPIL |
| Esomeprazole 40 MG cospharma EACH VIAL CONTAINS ESOMEPRAZOLE SODIUM EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 mg | 55070355/11.4.3/0703 | Registered | Not determined | None |
| Emanera 20 MG EACH CAPSULE CONTAINS ESOMEPRAZOLE MAGNESIUM DIHYDRATE EQUIVALENT TO ESOMEPRAZOLE 20,0 mg | 20 mg | 55091055/11.4.3/0910 | Old Medicine | Not determined | None |
| Emanera 40 MG EACH CAPSULE CONTAINS ESOMEPRAZOLE MAGNESIUM DIHYDRATE EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 mg | 55091155/11.4.3/0911 | Old Medicine | Not determined | None |
| Esomeprazole 10 granules cipla EACH SACHET CONTAINS ESOMEPRAZOLE MAGNESIUM DIHYDRATE 10,0 mg | 10Granules | 56015556/11.4.3/0155 | Registered | Not determined | None |
| Atalyd 10 granules EACH SACHET CONTAINS ESOMEPRAZOLE MAGNESIUM DIHYDRATE 10,0 mg | 10Granules | 560158.15556/11.4.3/0158.155 | Registered | Not determined | None |
| Truloc otc EACH TABLET CONTAINS: ESOMEPRAZOLE MAGNESIUM EQUIVALENT TO: ESOMEPRAZOLE 20,0 mg | 20 mgGastro-resistant film coated tablet | 57083357/11.4.3/0833Approved 27 January 2026 | Registered | Not determined | PIPIL |
| Esomeprazole 2,5 granules cipla EACH SACHET CONTAINS: ESOMEPRAZOLE MAGNESIUM DIHYDRATE 2,5 mg | 2,5Granules | 59006959/11.4.3/0069 | Registered | Not determined | None |
| Esomeprazole 5 granules cipla EACH SACHET CONTAINS: ESOMEPRAZOLE MAGNESIUM DIHYDRATE 5,0 mg | 5Granules | 59007059/11.4.3/0070 | Registered | Not determined | None |
| Atalyd 2,5 granules EACH SACHET CONTAINS: ESOMEPRAZOLE MAGNESIUM DIHYDRATE 2,5 mg | 2,5Granules | 590071.06959/11.4.3/0071.069 | Registered | Not determined | None |
| Atalyd 5 granules EACH SACHET CONTAINS: ESOMEPRAZOLE MAGNESIUM DIHYDRATE 5,0 mg | 5Granules | 590072.07059/11.4.3/0072.070 | Registered | Not determined | None |
| Nextell otc EACH TABLET CONTAINS ESOMEPRAZOLE MAGNESIUM DIHYDRATE EQUIVALENT TO ESOMEPRAZOLE 20,0 mg | 20 mgGastro-resistant tablets | 59022259/11.4.3/0222Approved 11 March 2025 | Registered | S2 | PIPIL |
| Esomeprazole 40 MG austell EACH TABLET CONTAINS ESOMEPRAZOLE MAGNESIUM DIHYDRATE EQUIVALENT TO ESOMEPRAZOLE 40,0 mg | 40 mg | 59022359/11.4.3/0223 | Cancelled | Not determined | None |
| Trusfluks 20 EACH TABLET CONTAINS ESOMEPRAZOLE 20,0 mg | 20 | 59032559/11.4.3/0325 | Registered | Not determined | None |
| Trusfluks 40 EACH TABLET CONTAINS ESOMEPRAZOLE 40,0 mg | 40 | 59032659/11.4.3/0326 | Registered | Not determined | None |
| Nexiam 40 MG iv EACH VIAL CONTAINS ESOMEPRAZOLE 40,0 mg | 40 mg | A380384A38/11.4.3/0384 | Registered | Not determined | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Esomeprazole magnesium dihydrate equivalent to esomeprazole
S4: Esomeprazole
- except when indicated for the temporary, short-term relief of heartburn and hyperacidity, subject to:
- a maximum daily dose of 20 milligrams
- a maximum treatment period of 14 days. (S2)
Consolidated Schedules 06 July 2026, lines 6239 to 6244
S2: Esomeprazole
- when indicated for the temporary, short-term relief of heartburn and hyperacidity subject to:
- a maximum daily dose of 20 milligrams
- a maximum treatment period of 14 days. (S4)
Consolidated Schedules 06 July 2026, lines 1921 to 1925
Pharmacological class: Other. (class 11.4.3)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Nexipraz otc, Ranbaxy Pharmaceutical (Pty) Ltd is scheduled S2 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.